These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31838901)

  • 1. Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methods.
    Li K; Li Z; Tao Y; Wang Q; Lai Y; Wu W; Peng S; Guo Z; Huang H
    Future Med Chem; 2019 Dec; 11(24):3125-3137. PubMed ID: 31838901
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds.
    Abdelhafez OM; Ahmed EY; Abdel Latif NA; Arafa RK; Abd Elmageed ZY; Ali HI
    Bioorg Med Chem; 2019 Apr; 27(7):1308-1319. PubMed ID: 30792101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of peptide inhibitor as a therapeutic agent against head and neck squamous cell carcinoma (HNSCC) targeting p38alpha MAP kinase.
    Gill K; Singh AK; Kapoor V; Nigam L; Kumar R; Holla P; Das SN; Yadav S; Subbarao N; Mohanti BK; Dey S
    Biochim Biophys Acta; 2013 Mar; 1830(3):2763-9. PubMed ID: 23238519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation.
    Astolfi A; Kudolo M; Brea J; Manni G; Manfroni G; Palazzotti D; Sabatini S; Cecchetti F; Felicetti T; Cannalire R; Massari S; Tabarrini O; Loza MI; Fallarino F; Cecchetti V; Laufer SA; Barreca ML
    Eur J Med Chem; 2019 Nov; 182():111624. PubMed ID: 31445234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases.
    Muth F; Günther M; Bauer SM; Döring E; Fischer S; Maier J; Drückes P; Köppler J; Trappe J; Rothbauer U; Koch P; Laufer SA
    J Med Chem; 2015 Jan; 58(1):443-56. PubMed ID: 25475894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation for the discovery of novel BRD4 inhibitors.
    Yan G; Hou M; Luo J; Pu C; Hou X; Lan S; Li R
    Chem Biol Drug Des; 2018 Feb; 91(2):478-490. PubMed ID: 28901664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma.
    De Monte C; Carradori S; Secci D; D'Ascenzio M; Guglielmi P; Mollica A; Morrone S; Scarpa S; Aglianò AM; Giantulli S; Silvestri I
    Eur J Med Chem; 2015 Nov; 105():245-62. PubMed ID: 26498571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Discovery of GIT1/β-Pix Inhibitors: Virtual Screening and Biological Evaluation of New Small-molecule Compounds with Anti-invasion Effect in Gastrointestinal Neoplasms.
    Wang C; Gu J; Li H; Zhao B; Yu T; Guo CL; Huang M; Jiang W; Ouyang Q
    Drug Des Devel Ther; 2024; 18():3075-3088. PubMed ID: 39050797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays.
    Wang L; Chen L; Yu M; Xu LH; Cheng B; Lin YS; Gu Q; He XH; Xu J
    Sci Rep; 2016 Jan; 6():18987. PubMed ID: 26732172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and molecular docking study of new benzofuran and furo[3,2-g]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitors.
    Amin KM; Syam YM; Anwar MM; Ali HI; Abdel-Ghani TM; Serry AM
    Bioorg Chem; 2018 Feb; 76():487-500. PubMed ID: 29310080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38α MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening.
    Astolfi A; Iraci N; Sabatini S; Barreca ML; Cecchetti V
    Molecules; 2015 Aug; 20(9):15842-61. PubMed ID: 26334265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-Based Structural Optimization of a Natural Product Itampolin A as a p38α Inhibitor for Lung Cancer.
    Liang JW; Wang MY; Wang S; Li XY; Meng FH
    Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30642059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
    Shah CP; Kharkar PS
    Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.
    Hao F; Tan M; Xu X; Han J; Miller DD; Tigyi G; Cui MZ
    Biochim Biophys Acta; 2007 Jul; 1771(7):883-92. PubMed ID: 17531530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer.
    Carabet LA; Lallous N; Leblanc E; Ban F; Morin H; Lawn S; Ghaidi F; Lee J; Mills IG; Gleave ME; Rennie PS; Cherkasov A
    Eur J Med Chem; 2018 Dec; 160():108-119. PubMed ID: 30326371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Molecular Docking of Novel Miscellaneous Chalcones as p38α Mitogen-Activated Protein Kinase Inhibitors.
    Zeid MM; El-Badry OM; Elmeligie S; Hassan RA
    Chem Biodivers; 2024 Apr; 21(4):e202400077. PubMed ID: 38359316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine Learning Assisted Discovery of Novel p38α Inhibitors from Natural Products.
    Shen T; Tao Y; Liu B; Kong D; Zhang R; Xiao W
    Comb Chem High Throughput Screen; 2023; 26(6):1214-1223. PubMed ID: 35786181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of small molecules targeting GRP78 for antiangiogenic and anticancer therapy.
    Qiao Y; Dsouza C; Matthews AA; Jin Y; He W; Bao J; Jiang F; Chandna R; Ge R; Fu L
    Eur J Med Chem; 2020 May; 193():112228. PubMed ID: 32199134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments of p38α MAP kinase inhibitors as antiinflammatory agents based on the imidazole scaffolds.
    Kong TT; Zhang CM; Liu ZP
    Curr Med Chem; 2013; 20(15):1997-2016. PubMed ID: 23317165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
    Guo F; Zhao S; Li X
    Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.